Edition:
United Kingdom

Indivior PLC (INDV.L)

INDV.L on London Stock Exchange

401.00GBp
19 Jan 2018
Change (% chg)

4.00 (+1.01%)
Prev Close
397.00
Open
398.40
Day's High
401.50
Day's Low
397.40
Volume
940,087
Avg. Vol
2,687,428
52-wk High
421.50
52-wk Low
246.50

Select another date:

Tue, Dec 19 2017

Indivior replaces $484 million in dollar, euro debt facilities

British drugmaker Indivior said it replaced all of its U.S. dollar and euro denominated outstanding term loans of about $484 million (£362 million).

UK's Indivior replaces $484 mln in dollar, euro debt facilities

Dec 19 British drugmaker Indivior said it replaced all of its U.S. dollar and euro denominated outstanding term loans of about $484 million.

BRIEF-‍Indivior Says Repricing And Maturity Extension Of Term Loan Facilities

* ‍INDIVIOR ANNOUNCES REPRICING AND MATURITY EXTENSION OF TERM LOAN FACILITIES AND REPLACEMENT OF CREDIT FACILITY​

BRIEF-Indivior Announces NDA Acceptance Of RBP-7000 Risperidone Monthly Depot

* INDIVIOR ANNOUNCES NDA ACCEPTANCE OF RBP-7000 RISPERIDONE MONTHLY DEPOT

U.S. FDA accepts application for Indivior's new schizophrenia drug

U.S. Food and Drug Administration (FDA) accepted Indivior's application for its new schizophrenia treatment, the British drugmaker said on Tuesday, boosting hopes of marketing the drug in the country.

U.S. FDA accepts application for Indivior's new schizophrenia drug

Dec 12 U.S. Food and Drug Administration (FDA) accepted Indivior's application for its new schizophrenia treatment, the British drugmaker said on Tuesday, boosting hopes of marketing the drug in the country.

BRIEF-‍Indivior Says FDA Accepts Application For New Schizophrenia Drug

* ‍INDIVIOR ANNOUNCES NDA ACCEPTANCE OF RBP-7000 RISPERIDONE MONTHLY DEPOT​

LPC-Indivior launches US$485m-equiv loan refi

LONDON, Dec 5 Pharmaceuticals company Indivior has launched a US$485m-equivalent loan to refinance existing debt, banking sources said.

Indivior drug to fight opioid addiction approved by U.S. FDA

Indivior's experimental drug to help fight America's growing opioid addiction crisis was approved by the U.S. Food and Drug Administration late on Thursday, boosting its sales prospects as competitors threaten revenues from an older product.

CORRECTED-Indivior drug to fight opioid addiction approved by U.S. FDA

Dec 1 Indivior's experimental drug to help fight America's growing opioid addiction crisis was approved by the U.S. Food and Drug Administration late on Thursday, boosting its sales prospects as competitors threaten revenues from an older product.

Select another date: